House Committee Considers FY27 Appropriations Bill with Boost to Cancer Research and Prevention Funding
WASHINGTON, D.C. – Tonight, the House Committee on Appropriations considered and approved its draft FY27 appropriations bill and accompanying House Report that includes increases for the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the Center for Disease Control and Prevention’s (CDC) Division of Cancer Prevention and Control (DCPC).
The House spending bill includes: $48.8 billion for NIH which is an increase of $100 million above FY26 funding, including $7.46 billion for NCI, which is an increase of $110 million, and $1.5 billion for the Advanced Research Projects Agency for Health (ARPA-H), which is level funding. The House Report also directs $240.049 million for the DCPC, an increase of $7 million over FY26 funding, and level funding at $246.5 million for CDC for tobacco prevention and cessation programs, including state grants, public education campaigns, surveillance, and cessation programs.
In response, Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) released the following statement:
“We thank the House Committee on Appropriations for advancing a bill that includes increased funding for NIH, NCI, and DCPC demonstrating a clear commitment to cancer patients, survivors and their families and those at risk of cancer. We are also pleased to see the support for ARPA-H and its important role in driving innovation in biomedical research.
“We also are grateful to the Committee for prioritizing funding for cancer screening and prevention along with at least level funding for tobacco prevention and cessation programs at the CDC. These investments help reduce the burden of cancer for all and ensure cancer is found earlier when it is easier to treat. At the same time, we remain concerned with the Administration’s elimination of CDC’s Office on Smoking and Health (OSH). ACS CAN strongly supports a fully restored OSH. With this important office no longer functioning, Big Tobacco is becoming even more aggressive in promoting its deadly products.
“As the appropriations process moves forward, we urge lawmakers to continue to recognize cancer as a national priority and advance a bipartisan spending bill that provides the highest possible increases for cancer research and prevention in FY27.”